Introduction
D-CDK4 also fail to induce G 1 arrest in cells lacking functional pRb (Lukas et al., 1994 (Lukas et al., , 1995a Koh et al., The activities of the cyclin-dependent kinases CDK4 and 1995; Medema et al., 1995) . Thus, the essential role of CDK6, which associate with D-type cyclins, and of CDK2, cyclin D-CDK4 is to inactivate pRb, thereby allowing which associates with cyclins E or A, are rate-limiting for E2F function. In summary, p16, cyclin D1-3, CDK4/6, progression through G 1 and into S-phase of the vertebrate pRb and E2F can be ordered within a single G 1 -regulatory cell cycle (reviewed by Sherr, 1994 Sherr, , 1995 . Besides pathway (the p16/pRb pathway). association with cyclins, the activity of CDKs is controlled
The p16/pRb pathway plays a critical role in suppressing by site-specific phosphorylation or dephosphorylation and tumorigenesis. Several of its components are genetically by association with a group of inhibitory proteins collectaltered in various human malignancies, resulting either in ively called CKIs (reviewed by Morgan, 1995; Sherr and oncogenic activation (cyclins D1, D2 and CDK4) or loss . CKIs of the Kip/Cip family, p21 Cip1/Waf1 , of function (pRb and p16) (reviewed by Hall and Peters, p27 Kip1 and p57 Kip2 , can associate with and inhibit all 1996). p16-null mice are viable, but develop malignancies known G 1 cyclin-CDK complexes. CKIs of the INK4 at increased rates (Serrano et al., 1996) . Strikingly, E2F-1-family, p16 INK4a , p15 INK4b , p18 INK4c and p19 INK4d bind null mice also have a tumour-prone phenotype (Field CDK4 and CDK6 and can interfere with cyclin-CDK interactions. Ectopic expression of CKIs induces G 1 arrest et al., 1996; Yamasaki et al., 1996) . Thus, the major role of E2F-1 in vivo might be to relay the repressive action complexes (Steiner et al., 1995) , and this also occurs through the suppression of p27 function (Perez-Roger of pRb, rather than its own activating function. It should be noted here that pRb has other targets in cells, which et al., 1997; J.Vlach and B.Amati, unpublished data) . However, no link was yet established between Myc and may also be critical for its growth-and tumour-suppressive functions Wang, 1997) .
p16 function.
In this study, we addressed whether cells infected with CDK2 and its partners, cyclins E and A, also phosphorylate and inactivate pocket proteins (Weinberg, 1995) .
retroviruses expressing G 1 cyclins, Cdc25A, E2F proteins or Myc could escape growth arrest induced by p16, and For example, in transfected SAOS-2 cells, the G 1 arrest induced by pRb is relieved by cyclins A or E, and this compared the effects of p16 and p27 in those cells. Our data demonstrate that cyclin E promotes cell proliferation correlates with hyperphosphorylation of pRb (Hinds et al., 1992) . Moreover, rapid activation of cyclin in the presence of elevated p16 levels, without inducing phosphorylation of pocket proteins. We suggest that cyclin upon induction of Myc (see below) coincides with pRb phosphorylation, whereas activation of cyclin A-CDK2 E cannot simply substitute for E2F function, but rather rescues it in the presence of p16. Reciprocally, the requireand cyclin D-CDK4 follow later in this particular system (Steiner et al., 1995) . Cyclin E-CDK2 appears to have ment for cyclin E in G 1 -S progression cannot be substituted by E2F. Finally, we demonstrate that Myc also bypasses additional function(s) in G 1 -S progression, distinct from pRb phosphorylation and E2F activation. First, inducible the p16/pRb pathway, and argue that this effect is mediated by the positive action of Myc on cyclin E. expression of cyclin E in Rat1 fibroblasts accelerates G 1 -S progression upon serum stimulation, without affecting the kinetics of pRb phosphorylation (Resnitzky and Reed, Results 1995). Second, G 1 arrest induced by dominant-negative CDK2 in U2OS cells is not relieved by the SV40 large T Myc and cyclin E prevent growth arrest by INK4 proteins antigen (LT), although LT rescues E2F function in this system (Hofmann and Livingston, 1996) . Third, unlike
The ability of Myc and various cell cycle regulators to suppress the growth-inhibitory function of INK4 family D-type cyclins, cyclin E is essential for cell cycle progression in pRb-deficient cells (Ohtsubo et al., 1995) .
proteins (p15, p16 or p18) was investigated in Rat1 fibroblasts as previously described for Myc and p27 (Vlach The functional hierarchy between the pRb/E2F pathway and cyclin E is complicated further by the finding that the et al., 1996) . First, cells were infected with retroviruses expressing Myc, Cdc25A, cyclins A and E, or D1-3. cyclin E gene is itself an E2F target. Cyclin E is induced by ectopic expression of E2F-1 (DeGregori et al., 1995a;  Serial infections using the pBabe series of retroviral vectors conferring resistance to neomycin (pBNeo), hygromycin Soucek et al., 1997) , and functional E2F-binding sites in the cyclin E promoter are activated by E2F-1 and repressed (pBHygro) or phleomycin (pBBleo) (Morgenstern and Land, 1990 ) allowed co-expression of up to three exoby pRb (Ohtani et al., 1995; Geng et al., 1996) . Furthermore, pRb-deficient fibroblasts express enhanced levels genous proteins prior to INK4 proteins, which were expressed with a puromycin resistance vector (pBPuro). of cyclin E . These observations suggest the existence of a positive feedback regulatory Following infection, cells were seeded at serial dilutions (e.g. 1/20, 1/200, 1/2000) in high serum, puromycinloop, in which cyclin E is not only an upstream regulator of E2F (via the phosphorylation of pRb), but also its selective medium. All non-infected cells had detached within 36 h of selection. Subconfluent populations of downstream effector. If the latter were true, deregulated cyclin E expression might be expected to bypass growth infected cells were harvested at 48 h after a 30 min pulse with bromodeoxyuridine (BrdU) for analysis of cell cycle arrest by p16 or pRb, exactly as E2F.
Myc, the transcription factor encoded by the c-myc distribution. Biochemical studies were performed at the same time. Dilute dishes were incubated further to assess proto-oncogene, was also linked to the activation of cyclin-CDK complexes in G 1 . Myc expression is strictly long-term proliferation and colony outgrowth. Expression of p16 induced accumulation of Rat1 cells controlled by mitogens, and is required for cell cycle entry and continued proliferation. Constitutive Myc expression in G 1 and suppressed colony outgrowth ( Figure 1A and B). Most cells in these p16-arrested populations remained prevents growth arrest by a variety of growth-inhibitory signals, and activation of a conditional Myc-estrogen isolated or formed sparse colonies, with no signs of apoptosis (data not shown). Retroviruses expressing receptor chimera (MycER) induces entry into the cell cycle (but also apoptosis) in the absence of mitogens cyclins A, D1, D2, D3 or Cdc25A did not prevent p16-induced cell cycle arrest, although all exogenous proteins (Eilers et al., 1991; Alexandrow et al., 1995; Hermeking et al., 1995; reviewed by Marcu et al., 1992; Henriksson were detectable by immunoblotting (data not shown and Table I ). In contrast, cells expressing Myc or cyclin E and Lüscher, 1996) . Since antimitogenic stimuli are mediated by CKIs, we investigated whether Myc could overentered S-phase and formed colonies efficiently in the presence or absence of p16 ( Figure 1A and B, and Table come the growth-inhibitory function of these proteins. We previously reported that constitutive expression of Myc I). Similar results were obtained with NIH-3T3 cells (data not shown). As for p16, Myc and cyclin E bypassed cell abrogates growth arrest by retrovirally expressed p27, by preventing its association with cyclin E-CDK2 (Vlach cycle arrest by p15 and p18 in Rat1 cells ( Figure 1C ). Immunoblot analysis revealed that Myc and cyclin E did et al., 1996) . Myc also induces transcription of the CDKactivating phosphatase Cdc25A (Galaktionov et al., 1996) , not suppress expression of p16, p15 or p18 ( Figure 2A ), and had no significant effect on the expression of the which appears not to be involved in rescue of p27-induced arrest (Vlach et al., 1996) . Moreover, MycER activation cellular p16 targets CDK4, CDK6 and D-type cyclins, apart for a slight increase in cyclin D2 levels in Myc cells in quiescent fibroblasts rapidly activates cyclin E-CDK2 
Data from this work are compiled together with data from Vlach et al. (1996) , for a direct comparison between p16 and p27. ϩ andindicate proliferating and arrested cells, respectively, according to BrdU incorporation and colony outgrowth assays. All cells proliferated after the first infection (INF. 1) as efficiently as control, vectorinfected cells. n.d., not determined.
hypophosphorylated ( Figure 3A and B, lane 2). p107, in particular, was present as a doublet of both hyper-and hypophosphorylated forms in p27-arrested cells (Vlach et al., 1996 and Figure 3A ), whereas INK4-arrested cells contained only the lower band. Strikingly, Myc and cyclin E did not reverse the effect of p16 on pRb family proteins, which were also mostly hypophosphorylated in proliferating Mycϩp16 or cyclin Eϩp16 cells ( Figure 3B , lanes 4 and 6). This observation was reproduced for pRb and p107 in NIH-3T3 cells ( Figure 3C ) in which p16 induced no changes in p130 mobility (data not shown). Thus, pocket proteins were hypophosphorylated in growing Mycϩp16 or cyclin Eϩp16 cells, unlike in control immunoblotting of p16 ( Figure 2C ). Retroviral expression of CDK4 (wild-type or a kinase-defective mutant) or CDK6 also prevented p16-induced arrest (data not shown), ( Figure 2B ). In conclusion, Myc and cyclin E overcome growth arrest by INK4 proteins.
supporting the notion that these kinases were the p16 targets in cells. However, we were unable to demonstrate directly that p16 suppressed the kinase activities associated
Myc and cyclin E do not prevent p16-induced dephosphorylation of pocket proteins with CDK4, CDK6 or D-type cyclins. In summary, Myc and cyclin E promote cell growth in the presence of p16 To investigate the effects of Myc or cyclin E on INK4 function, we examined the relative phosphorylation state and hypophosphorylated pocket proteins. of pRb, p107 and p130 by immunoblot analysis. In INK4-arrested Rat1 cells, pocket proteins were found exclusively Retrovirally expressed pRb cooperates with p16 and is bypassed by Myc or cyclin E in their hypophosphorylated, faster migrating form ( Figure  3A) , consistent with the induction of G 1 arrest. Although If Myc and cyclin E bypass pRb activation by p16, they might rescue growth in the presence of elevated pRb levels. pRb levels were decreased consistently in p16-arrested cells in comparison with controls, the remaining pRb was
To address this question, we constructed retroviruses more, HApRbϩp16 cells showed a marked increase in of pRb, p107 and p130. At this stage, however, inactivation of pocket proteins by a specific cyclin E-mediated phosphorylation event could not be ruled out. To address the functional status of pRb, we sought to analyse its interaction with E2F-1, -2 or -3. Because these proteins were undetectable in Rat1 cells, we co-expressed Myc and cyclin E with an E2F variant (HA-E2F1eco) which interacts with pRb but does not bind DNA (Johnson et al., 1993) . In spite of a slight residual activity of E2F1eco (see Figure 9C ), growth of E2F1eco cells was suppressed by p16 and restored by Myc or cyclin E (data not shown).
Following superinfection with the p16 retrovirus, the interactions between HA-E2F1eco and pRb were monitored by immunoprecipitation with anti-E2F-1 antibodies, followed by pRb immunoblotting ( Figure 6A , panels ii). Total and immunoprecipitated HA-E2F1eco levels were constant throughout the experiment (panels iii and iv), and no pRb was detectable in anti-E2F-1 immunoprecipitates from cells lacking HA-E2F1eco (panels ii, lanes 0). The results showed that p16 increased the association of pRb with HA-E2F1eco in control cells ( Figure 6A , lanes 1 and 2), as well as in cells expressing Myc (lanes 3 and 4) or cyclin E (lanes 5 and 6), even though total pRb levels were decreased by p16 in all cells ( Figure 6A , panels i; Figure 3B ). The same experiment was repeated in cells expressing exogenous HApRb together with HA-E2F1eco, and similar controls were provided ( Figure 6B ). The result was identical, showing that the association of pRb (endogenous plus exogenous) with HA-E2F1eco was induced by p16 in all cells (panels ii). Taken together, these experiments demonstrate that Myc and cyclin E do not interfere with p16-induced activation of pRb. Similar experiments were performed to assess the func- This interaction was detectable in growing Rat1 cells, but was not increased further upon expression of p16 (data prevented cell cycle arrest ( Figure 5C ) and the appeareance of the 'flat' phenotype (data not shown). Although the not shown).
To analyse E2F-pocket protein complexes further and differentially phosphorylated forms of HApRb were difficult to resolve on immunoblots, a significant fraction of to assess the amount of 'free' E2F activity, we performed gel retardation assays with retrovirally infected cells. As the protein was found in its faster-migrating form in all p16-expressing cells ( Figure 5D ). These data confirmed detection of E2F-DNA complexes was very difficult in Rat1 cells, we used NIH-3T3 cells, which showed similar two important points: first, that pRb levels are limiting for p16-induced arrest; second, that Myc and cyclin responses to p16 ( Figure 3C and data not shown). Three DNA-binding complexes specific for E2F sites were E rescue cell growth without preventing p16-induced dephosphorylation of either endogenous or exogenous identified with oligonucleotide competition studies (complexes A, B and C; Figure 8 ). Complex A corresponds to pRb.
'free' E2F-DP dimers, as treatment of the extracts with deoxycholate (DOC) resulted in loss of B and C and a
Pocket proteins are functional in growing Myc⍣p16 or cyclin E⍣p16 cells simultaneous increase in the amount of complex A. The E2F species in complex A was most likely E2F-4, since The data presented so far suggested that Myc and cyclin E promote cell growth in the face of p16-induced activation it co-migrated with the major E2F-DNA complex seen in Immunoblotting was performed to visualize the immunoprecipitated HA-E2Feco with anti-HA antibodies (panels iii) and the associated pRb (endogenous and exogenous) with anti-pRb antibodies (panels ii). Total levels of pRb (panels i) and HA-E2F1eco (panels iv) were also measured. nd: not determined.
NIH-3T3 cells expressing recombinant E2F-4, but not E2F-1, -2, -3 or -5 (data not shown). The composition of complex B, which was not supershifted by any tested antibody, is unknown. Complex C could be supershifted by p107 or CDK2 antibodies (data not shown) and presumably also contained cyclins E or A (Lees et al., 1992; Schwarz et al., 1993; Cobrinik, 1996) . No other pocket protein-E2F complexes were detected in growing NIH-3T3 cells, as previously described (Lam and Watson, 1993; Schwarz et al., 1993) . Two major points can be made concerning the effects of Myc, cyclin E and/or p16 on E2F DNA-binding complexes ( Figure 8 ). First, p16 alone reduced the amount of 'free' E2F-4-DP (complex A) present in control cells. This decrease was minimized in the presence of Myc or cyclin E. Second, complex C was increased in response to p16 in Myc or cyclin E cells. The lack of complex C cells. In summary, the results from co-immunoprecipitation and gel retardation studies show that Myc and cyclin E prevent growth arrest by p16 without interfering with the results is that cyclin E and Myc restore activity of some E2F complexes (see Discussion), although alternative ability of pRb, p107 and p130 to associate with their respective E2F targets.
routes to restore expression of E2F target genes cannot be ruled out.
If cyclin E acted solely through E2F, E2F proteins E2F proteins bypass p16-, but not p27-induced arrest: implications for an E2F-independent would be expected to bypass G 1 arrest not only by p16, as previously reported (DeGregori et al., 1995b; Lukas
function of cyclin E
The data presented so far may be interpreted in two et Mann and Jones, 1996) , but also by p27, which inhibits cyclin E-CDK2 function. To address this alternative ways. First, cyclin E or Myc might allow cell growth in the absence of E2F function. Second, cyclin E question, we infected Rat1 cells with retroviruses expressing HA-tagged versions of E2F-1 to -5, as well as or Myc might rescue the transcriptional activity of some E2F complexes in the presence of active pRb, p107 E2F-1Δ5 and E2F-4Δ4 (two mutants which are not bound by pocket proteins; Krek et al., 1994; Vairo et al., 1995) , and p130. Unfortunately, we could not detect significant regulation of stably or transiently transfected E2F-responsthe DNA-binding mutant E2F-1eco and a T7-tagged form of DP-1. Expression of all these proteins was detected ive reporter genes by retrovirally expressed p16. However, cyclin A and CDC2 protein levels were suppressed by readily by immunoblot ( Figure 9A and B and data not shown). E2F-1, -2, -3 and E2F-1Δ5 prevented growth p16 in control cells, but not in cells expresing cyclin E or Myc ( Figure 2B ). The simplest interpretation of these arrest by p16, whereas E2F-4, E2F-5 and DP-1 were inactive ( Figure 9C and Table I ), consistent with previous reports Mann and Jones, 1996) . The lack of activity of E2F-4 and E2F-5 may be due to the combination of several parameters, including interaction with pocket proteins and/or inefficient dimerization. Indeed, E2F-4Δ4 had a weak rescuing activity, and coexpression with DP-1 allowed E2F-4 and E2F-4Δ4 to fully rescue p16-induced arrest ( Figure 9 ; . In contrast to the p16 results, none of the E2F proteins prevented growth arrest by p27 ( Figure 9D and work), but not by p27 (Vlach et al., 1996) (Table I ). In in pools infected with viruses expressing HA-tagged E2F proteins and summary, although E2F-1, -2 and -3 were expressed at for which its targets lie outside of the pRb/E2F pathway.
CDK6 and induced activation of pocket proteins and their
Discussion association with E2Fs. This effect was not transient since cells expressing cyclin E and p16 sustained long-term Cyclin E bypasses activation of the p16/pRb growth-inhibitory pathway proliferation with hypophosphorylated, active pocket proteins. Cyclins A, D1, D2 and D3 were inactive in bypassing Previous observations suggested that cyclin E has a function distinct from pRb phosphorylation required for p16-induced arrest in this system (Table I) . In normal cells, cyclin E expression is under the control G 1 -S progression (see Introduction; Ohtsubo and Roberts, 1993; Resnitzky and Reed, 1995; Hofmann and Livingston, of E2F and pRb. The promoter of the cyclin E gene contains E2F-responsive elements and is repressible by 1996). We demonstrate here that cyclin E is sufficient to bypass growth arrest by p16, and allows cell proliferation pRb (Ohtani et al., 1995; Botz et al., 1996; Geng et al., 1996) . Consistent with this, pRb-deficient cells showed in the presence of active pRb family proteins. Infection with a p16-expressing retrovirus arrested Rat1 cells in G 1 , enhanced expression of cyclin E , and overexpression of E2F-1 induced cyclin E (DeGregori but had no effect on cells expressing exogenous cyclin E. p16 remained active in these cells since it bound its target et al., 1995a; Soucek et al., 1997). Since cyclin E-CDK2
complexes also contribute to pRb phosphorylation and activating complexes. Compatible with, but not proving, this hypothesis, our gel retardation assays showed that inactivation, these observations led to the proposal that a positive feedback loop may operate in late G 1 (see p16 in cyclin E-expressing cells induced formation of E2F-4/DP/p107/cyclin-CDK2 DNA-binding complexes. Introduction). According to this model, the increase in cyclin E-CDK2 activity would contribute to further activOn the other hand, cyclin E also favored the maintenance of 'free' E2F-4-DP complexes. However, whether and ation of E2F, and thus to enhanced transcription of the cyclin E gene. The outcome of such a loop would be to how E2F contributes to cyclin E function in overcoming the p16 block remains to be investigated. boost activation of both E2F and cyclin E. However, such a model does not predict which of E2F or cyclin E, or
The functional relationship of cyclin E and E2F is highlighted further by studies in Drosophila embryos. both, performs the rate-limiting downstream function in S-phase entry.
E2F-or cyclin E-deficient embryos fail to enter S-phase of embryonic cycle 17 in the endocycling cell compartment Ectopic activation of an essential downstream effector may bypass the presence of active pRb. This is the case (Knoblich et al., 1994; Duronio et al., 1995) . In this tissue, the limiting downstream target of E2F for S-phase for E2F-1, which suppresses both pRb- (Zhu et al., 1993; Qin et al., 1995) and p16-induced G 1 arrest, in conditions entry is cyclin E. Ectopic E2F-DP expression requires cyclin E function to trigger S-phase entry, although the in which cellular pRb remains hypophosphorylated Mann and Jones, 1996 ; this work and transcriptional function of E2F itself does not require cyclin E (Duronio et al., 1995 (Duronio et al., , 1996 . Conversely, ectopic unpublished data). Moreover, adenovirus-mediated gene transfer of E2F-1 suppressed G 1 arrest and allowed compleexpression of cyclin E can trigger S-phase entry, but requires expression of additional E2F target genes. Cyclin tion of a mitotic cycle in the presence of either p16 or p27, leading to the suggestion that E2F-1 allows S-phase E expression induces E2F-dependent transcription (Duronio and O'Farrell, 1995) , most likely through entry in the absence of cyclin E function (DeGregori et al., 1995b) . In those studies, however, E2F-1 was phosphorylation of the pRb homolog RBF (Du et al., 1996) . In the central nervous system, cyclin E is expressed strongly overexpressed, which may have led to nonphysiological effects. Indeed, we and others (Mann and by an E2F-independent mechanism, and is required upstream of E2F function (Duronio et al., 1995) . Thus, found that p27 is dominant over E2F-1. In fact, E2F proteins behaved similarly to cyclin E, which the dependence of one gene upon the other can be reversed in different tissues or stages, depending on which gene rescued p16-, but not p27-induced arrest (Table I) , owing to the inhibition of cyclin E by p27 (Vlach et al., 1996) . product becomes rate-limiting. In summary, in Drosophila as in mammalian cells, cyclin E is both a downstream These observations imply that E2F activity cannot bypass inhibition of cyclin E-CDK2 by p27, even though it can effector and an activator of E2F. In addition to this crossregulation, both E2F and cyclin E have at least one bypass activation of pRb by p16. Two conclusions can be drawn from these studies: first, that E2F is unable to independent downstream function required for S-phase entry. promote growth in the absence of cyclin E activity; second, that cyclin E has at least one E2F-independent function What might be the E2F-independent function of cyclin E? In vitro experiments suggest that it might be linked to required for S-phase entry. Such a function of cyclin E-CDK2 was also implied by the observation that the the initiation of DNA replication. In Xenopus extracts, which replicate in the absence of transcription (and thus SV40 LT restored E2F activity, but not cell cycle progression, in the presence of transiently expressed dominantof E2F activity), addition of p21 blocked DNA replication, and cyclins A or E could overcome this block (Strausfeld negative CDK2 (Hofmann and Livingston, 1996) .
If cyclin E has a function downstream of E2F, could it et al., 1994) . In addition, G 1 -phase HeLa cell nuclei initiated DNA replication when co-incubated with S-phase be sufficient for S-phase entry in the absence of E2F activity? A direct test of this question would be to block nuclear and cytoplasmic extracts. The nuclear extract could be replaced by cyclin E-CDK2 or cyclin A-CDK2 E2F activity in cells expressing cyclin E. We attempted this with a dominant-negative mutant of DP-1 (DN-DP-1) (Krude et al., 1997) . A direct involvement of cyclin-CDK activity in triggering the onset of DNA replication has also which blocks E2F function and arrests cells in G 1 in transient transfections (Wu et al., 1996) . However, retrobeen demonstrated in yeast (reviewed by Stillman, 1996) . viral expression of DN-DP-1 (or a variant tagged with a nuclear localization sequence) had no effect on cell cycle
Rescue of p16-induced arrest by Myc is most likely a cyclin E-mediated activity progression. Thus DN-DP-1 may effectively block E2F activity in vivo only if overexpressed, which may have
We show here that Myc bypasses p16/pRb-induced growth arrest. Like other biological activities of Myc (Henriksson non-specific side effects. A direct test of the requirement for E2F in the presence of cyclin E awaits alternative and Lüscher, 1996; Vlach et al., 1996) , this effect depends upon the formation of transcriptionally active Myc-Max ways to ablate E2F activity. In spite of this, several observations suggest that cyclin E does not bypass, but dimers (unpublished data). As for cyclin E, cells expressing Myc and p16 proliferate with hypophosphorylated, active rather rescues E2F activity by an alternative route in the presence of p16 and active pRb. In transient transfections, pocket proteins. Thus, Myc and cyclin E rescue p16-induced arrest by indistinguishable mechanisms. The main cyclin E relieved p16 (but not p27)-mediated repression of the cyclin A promoter (Zerfass-Thome et al., 1997) . In rationale for these findings is provided by the notion that Myc can act as an upstream activator of cyclin E-CDK2. our experiments, cyclin E rescued the expression of cellular cyclin A and CDC2 in the presence of p16.
Constitutive expression of Myc prevented inactivation of cyclin E-CDK2 and cell cycle arrest by retrovirally Zerfass- Thome et al. (1997) proposed that cyclin E-CDK2 binding to E2F-4/DP/p107 results in the formation of expressed p27, through the sequestration of p27 into heat-labile complexes (Vlach et al., 1996) (Table I ). The same Hall and Peters, 1996) . These observations strongly suggest that other genetic lesions resulting in the functional mechanism was involved in activation of cyclin E-CDK2 by MycER in quiescent fibrobasts (Steiner et al., 1995;  suppression of the p16/pRb pathway should also be tumorigenic. Perez-Roger et al., 1997; J.Vlach and B.Amati, unpublished data) . In some cell lines, p27 has a role in limiting Recently, aberrant expression of cyclin E has been linked to tumorigenesis (see, for example, Keyomarsi the rate of G 1 -S progression during proliferation (Coats et al., 1996) , whereas constitutive expression of cyclin E et al., 1994; Porter et al., 1997) . It was suggested that cyclin E-CDK2 replaces CDK4 function in tumor cells (Ohtsubo and Roberts, 1993) or Myc (Karn et al., 1989) can accelerate it. These observations suggest that Myc, that express high p16 levels by phosphorylating pRb (Gray-Bablin et al., 1996) . However, our data show that by suppressing p27 function, can accelerate the activation of cyclin E during G 1 . This, through the positive cyclin cyclin E bypasses p16/pRb function through a different pathway. Although cyclin E was also shown to have a E-E2F feedback loop discussed above, should further enhance cyclin E expression. Consistent with this view, mild oncogenic potential in transgenic mice (Bortner and Rosenberg, 1997) , its causal involvement in human tumors MycER activation induced expression of E2F target genes (Jansen-Dürr et al., 1993; Pusch et al., 1997b) , and in remains to be investigated. The widespread oncogenic potential of myc family particular of cyclin E (Perez-Roger et al., 1997; Pusch et al., 1997a) , although there is no evidence that any of genes and their involvement in numerous malignancies in both humans and animals are well established (reviewed these genes is a direct transcriptional target of Myc. The cdc25A gene, on the other hand, is a Myc target by Marcu et al., 1992; Garte, 1993) . As discussed above, Myc antagonizes p27 function, but loss of p27 is not per (Galaktionov et al., 1996) . However, overexpression of Cdc25A rescued neither p16-nor p27-induced arrest se a tumorigenic event (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . This suggests that Myc (Vlach et al., 1996;  Table I ), suggesting that additional Myc/Max target genes are involved.
may have other direct targets, which may include the p27-related CKIs p21 and p57, as well as p53 (Hermeking In addition to its upstream action, Myc may also be a downstream target of pocket proteins. First, the c-myc et al., 1995). Independently of this aspect, bypassing the tumour suppressor function of the p16/pRb pathway may gene was proposed to be an E2F target; however, unlike other E2F targets, it was not induced upon adenovirus be an important, if not the essential, aspect of Myc's oncogenic activity. In support of this hypothesis, fibroblasts expression of E2F-1 (DeGregori et al., 1995a) . Second, p107 can associate with the Myc protein and suppress its isolated from p16-null mouse embryos are transformed by ras alone, whereas wild-type cells undergo premature transactivation potential in transient transfections (Beijersbergen et al., 1994; Gu et al., 1994; Hoang et al., senescence (Serrano et al., 1996 (Serrano et al., , 1997 . On the other hand, transformation of wild-type cells requires cooperation of 1995). In these assays, Myc bypassed cell cycle arrest by p107, but not by pRb (Beijersbergen et al., 1994) . In ras with immortalizing oncogenes, such as c-myc (Land et al., 1983) . Thus, loss of p16 mimics myc activation, contrast, microinjected GST-Myc proteins prevented cell cycle arrest by pRb (Goodrich and Lee, 1992) . Since the and vice versa. Based on this, we predict that myc activation may partly release the pressure to mutate mechanisms underlying these effects were not studied, these discrepancies remain unexplained and illustrate the components of the p16/pRb pathway during tumorigenesis. potential dangers of overexpression. Although we cannot rule out that the Myc-p107 interaction plays a role in Materials and methods overcoming p16 (or p27)-induced arrest by Myc, it is unlikely to account for our findings. First, in our system,
Retroviral expression vectors
we did not detect the Myc-p107 interaction. Second, cells
The retroviral vectors pBabe-Puro (pBP), -Bleo (pBB), -Neo2 (pBN2) expressing Myc and p16 proliferate in the presence of not and-Hygro2 (pBH2) were described previously (Morgenstern and Land, 1990; Vlach et al., 1996) . cDNAs encoding human cyclins A, D1-3 and only active p107, but also of pRb and p130. Third, Myc E, as well as Myc, HApRb, HAΔp34, HA-E2F-1 to -3 and HA-E2F1eco was expressed at low levels in our studies, making titration proteins were subcloned in pBN2, pBH2 and/or pBB, as required. HAof p107 by Myc a very unlikely mechanism.
E2F-4 and HA-E2F-4Δ4 were expressed from the pRcCMVneo retroviral In summary, we propose that the overcoming of p16-vector (a kind gift from W.Krek). cDNAs encoding the human CKIs induced growth arrest by Myc is mainly the consequence p15, p16, p18 and p27 were subcloned in pBP.
of its upstream action on cyclin E-CDK2: Myc suppresses Retroviral infections, cell cycle analysis and biochemical p27 function, allowing an elevation of cyclin E activity analysis above the threshold required to bypass the p16/pRb block.
High-titer retroviral supernatants (ഛ5ϫ10 6 /ml) were generated as In situations in which p16 is not overexpressed, the same described (Vlach et al., 1996) . Infected Rat1 or NIH-3T3 cells were activity of Myc accelerates hyperphosphorylation of pRb selected with the appropriate drug: G418 (Calbiochem, 1000 μg/ml), hygromycin (Calbiochem, 150 μg/ml), phleomycin (Cayla, 50 μg/ml) or by cyclin E-CDK2 in concert with cyclin D-CDK4. puromycin (Sigma, 2.5 μg/ml). Serial infections of cell pools, preparation of cell lysates and biochemical analysis (immunoblots, immunoprecipitRelevance of bypassing p16/pRb function for ations) were as previously described (Vlach et al., 1996) . Gel retardation tumorigenesis assays were performed from infected cells as previously described
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